| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 274 |
| 1 | CLOZAPINE | 90 |
| 2 | OMEPRAZOLE MAGNESIUM | 87 |
| 3 | OMEPRAZOLE | 76 |
| 4 | INFLIXIMAB | 66 |
| 5 | PREDNISONE | 66 |
| 6 | AZATHIOPRINE | 61 |
| 7 | METHOTREXATE SODIUM | 61 |
| 8 | FUROSEMIDE | 60 |
| 9 | ASPIRIN | 59 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0139 |
| 1 | CEFOTETAN DISODIUM | 1 | 0.0089 |
| 2 | CEFOTETAN | 1 | 0.0075 |
| 3 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| 4 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 1 | 0.0067 |
| 5 | THROMBIN HUMAN AND FIBRINOGEN | 2 | 0.0060 |
| 6 | INFLIXIMAB-DYYB | 20 | 0.0058 |
| 7 | ORPHENADRINE CITRATE | 3 | 0.0048 |
| 8 | NEOSTIGMINE METHYLSULFATE | 2 | 0.0046 |
| 9 | CETYLPYRIDINIUM CHLORIDE | 3 | 0.0046 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 183 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 137 |
| 2 | Atypical Antipsychotic [EPC] | 136 |
| 3 | Benzodiazepine [EPC] | 130 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 117 |
| 5 | Proton Pump Inhibitor [EPC] | 110 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 87 |
| 7 | Interleukin-23 Antagonist [EPC] | 73 |
| 8 | Osmotic Laxative [EPC] | 70 |
| 9 | Platinum-based Drug [EPC] | 68 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 1 | Human Blood Coagulation Factor [EPC] | 2 | 0.0024 |
| 2 | GLP-2 Analog [EPC] | 21 | 0.0016 |
| 3 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 4 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 5 | Interferon gamma [EPC] | 2 | 0.0014 |
| 6 | Vitamin K [EPC] | 12 | 0.0014 |
| 7 | Provitamin D2 Compound [EPC] | 40 | 0.0013 |
| 8 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 9 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 8 | 0.0010 |